Title of Invention: Antibacterial agents and compositions, methods and systems employing same Abstract: The present invention relates to antibacterial agents, more particularly salicylanilide substituted compositions, preferably monosubstituted salicylanilide compositions, most preferably monohalogenated salicylanilide compositions, useful in antibacterial compositions, bacteria-reducing systems, antibacterial products and bacteria-reducing methods. Summary of Invention: FIELD OF THE INVENTION &lsqb;0002&rsqb; The present invention relates to antibacterial agents, more particularly salicylanilide substituted compositions, preferably monosubstituted salicylanilide compositions, most preferably monohalogenated salicylanilide compositions, useful in antibacterial compositions, bacteria-reducing systems, antibacterial products and bacteria-reducing methods. BACKGROUND OF THE INVENTION &lsqb;0003&rsqb; Consumers are very conscientious about cleanliness and/or sanitization, especially when it comes to dishes, utensils, tableware, cookware, and cleaning articles, such as sponges, wash cloths, etc.. that are typically found and/or used in kitchens and bathrooms at home and away from home, such as in restaurants. Other areas of interest are textiles, fabrics and garments that come into contact with consumers. Accordingly, there is a need for a bacteria-reducing system and method that sanitizes such articles, such as garments, textiles, sponges, dishes, tableware, and wash cloths. &lsqb;0004&rsqb; The prior art is replete with detergent compositions containing multi-halogenated salicylanilides, especially tribromosalicylanilide and tetrachlorosalicylanilide; see U.S. Pat. Nos. 2,906,711; 3,968,210; 3,989,827; and 4,061,603; German &num;2,157,209; and British &num;848,306. &lsqb;0005&rsqb; The art teaches that salicylanilides, when used individually, are not effective against gram negative bacteria, only gram positive bacteria (Natarajan et al., 1992, Indian Drugs 29:545-552). Additionally, the art teaches that, in a detergent matrix, mono-halogenated salicylanilides are ineffective; multi-halogenated salicylanilides are required for efficacy. In fact, the art teaches that mono-halogenated salicylanilides are not efficacious in a detergent matrix (Lemair et al., 1961, J. Pharmaceutical Sciences, 50:831-837) with the exception of monohalogenation on the aniline ring of thiosalicylanilides (British patent &num;1,088,498). The mono halogenated thiosalicylanilides in British &num;1,088,498 were taught to be effective only against gram-positve bacteria, not against gram-negative bacteria. &lsqb;0006&rsqb; Although multi-halogenated salicylanilides are effective in a detergent matrix, these compounds have not enjoyed widespread use due to a variety of reasons, including but not limited to problems encountered in formulating these agents. Accordingly there remains a need for an effective means of formulating salicylanilide type compounds, as well as a need for derivatives that are effective against both gram positive and gram negative bacteria. SUMMARY OF THE INVENTION &lsqb;0007&rsqb; The present invention meets and fulfills the needs identified above by providing antibacterial compositions, methods and systems that employ certain antibacterial agents, preferably substituted salicylanilide compounds. &lsqb;0008&rsqb; Surprisingly, it has been found that certain classes of salicylanilide compounds, which were originally identified as having little or no antibacterial properties, exhibit antibacterial properties in certain formulations. &lsqb;0009&rsqb; In one aspect of the present invention, an antibacterial composition comprising an antibacterial agent, preferably a substituted salicylanilide compound of formula I, 1 &lsqb;0010&rsqb; wherein m is an integer from 0 to 4; n is an integer from 0 to 5; the sum of m&plus;n is greater than zero; a is 0 or 1; b is 0 or 1; g is 0 or 1; when b is 0, one of a and g must be 0; Z and Z′ are independently selected from 0 and S; X and X′, when present, are selected from O, S, and NR1, where R1 is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; T, when present, is selected from C&boxH;O, C&boxH;S, S&boxH;O, and SO2; when T is S&boxH;O or SO2, X and X′ may not be S; when either a, b or g is 1 for a radical R—(X)a—(T)b—(X′)g—. R for that radical is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; when a, b and g are all 0 for a radical and neither Z nor Z′ is S, R for that radical may be further selected from the group consisting of F, Cl, Br, I, CN, R2N→O, NO2; when Z or Z′ is S, R for that radical may be further selected from the group consisting of CN, R2N→O, NO2; when all a, b and g are 0, at least one R must be non-H; further provided that the total number of halogen atoms in the molecule excluding any present in G does not exceed two; G is H, a suitable charge balancing counterion (Mn&plus;)1/n, or a cleaveable group selected from the group consisting of Si((O)pR2)3, where p is independently 0 or 1; C(O)q((O)pR2)r, wherein p is independently 0 or 1 and when q is 1, r is 1, and when q is 0, r is 3; R2 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof; and &lsqb;0011&rsqb; B) at least one additional component selected from the group consisting of: &lsqb;0012&rsqb; i) at least 1 wt % of a surfactant, wherein the ratio of the weight of the surfactant divided by the weight of said compound I is greater than or equal to 1.0; &lsqb;0013&rsqb; ii) from 0.5% to 90% of a solvent whose Hildebrand solubility parameter dS (cal/cm3)1/2 meets the following criterion: 5<dS<20, wherein a 10 wt % aqueous solution of this composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the phenol or thiophenol of formula I, or when G is not H, the pKa of the phenol or thiophenol of formula I that results from replacing G with H; &lsqb;0014&rsqb; iii) a perfume wherein the perfume has a C log P greater than or equal to 2.0. &lsqb;0015&rsqb; iv) an enzyme from 0.001 to 1.0% by weight of the composition; &lsqb;0016&rsqb; v) mixtures thereof; &lsqb;0017&rsqb; is provided. &lsqb;0018&rsqb; In another aspect of the present invention, an antibacterial composition comprising a substituted phenol or thiophenol compound of formula II: 2 &lsqb;0019&rsqb; wherein m is an integer from 0 to 4; a is 0 or 1; b is 0 or 1; g is 0 or 1; when b is 0, one of a and g must be 0; Z is selected from O and S; X and X′, when present, are selected from O, S, and NR1; when either a, b or g is 1 for a radical R—(X)a—(T)b—(X′)g—, R for that radical is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; when a, b and g are all 0 for a radical and Z is O, R for that radical may be further selected from the group consisting of F, Cl, Br, I, CN, R2N→), NO2; T, when present, is selected from C&boxH;O, C&boxH;S, S&boxH;O, and SO2; when T is S&boxH;O or SO2, X and X′ may not be S; Y is a radical comprising at least 1 but no more than 20 carbon atoms and containing a substituent —X″—H, where X″ is selected from O, S, and N—(T′)b′—(X′″)a′—R2, where a′ is 0 or 1, b′ is 0 or 1, and X′″, when present, is selected from O, S, and NR2; R2 is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; T′, when present, is selected from C&boxH;O, C&boxH;S, and SO2; when T′ is SO2, X′″ may not be S; G is H, a suitable charge balancing counterion (Mn&plus;)1/n, or a cleaveable group selected from the group consisting of Si((O)pR3)3, where p is independently 0 or 1; C(O)q((O)pR3)r, wherein p is independently 0 or I and when q is 1, r is 1, and when q is 0, r is 3; R3 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof; the parameter dZ-H, the center to center distance from the phenolic oxygen atom or the thiophenolic sulfur atom to the H atom of —X″—H, must satisfy the following criterion in at least ore rotational conformation of the compound II: 1.0 &angst;&lE;dZ-H&lE;4.0 &angst;; &lsqb;0020&rsqb; wherein when G is H or replaced by H, the pKa of the substituted phenol or thiophenol, or resulting substituted phenol or thiophenol is from about 5 to about 11; and &lsqb;0021&rsqb; B) a surfactant wherein the ratio of the weight of the surfactant divided by the weight of the substituted compound II is greater than or equal to 1.0 and further provided that the surfactant is 1 wt % or greater of the composition; and &lsqb;0022&rsqb; C) from 0.5% to 90% of a solvent whose Hildebrand solubility parameter dS (cal/cm3) meets the following criterion: 5<dS<20; and &lsqb;0023&rsqb; D) optionally, a surfactant containing a nitrogen head group; quaternary ammonium compound; an amphoteric surfactant; a zwitterionic surfactant; or a primary, secondary, or tertiary amine based surfactant, &lsqb;0024&rsqb; further provided that a 10 wt % aqueous solution of this composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the substituted phenol or thiophenol or, when G is not &lsqb;0025&rsqb; H, the resulting substituted phenol or thiophenol of formula II, is provided. &lsqb;0026&rsqb; In yet another aspect of the present invention, a bacteria-reducing system comprising a substituted salicylanilide compound of formula I. 3 &lsqb;0027&rsqb; wherein m is an integer from 0 to 4; n is an integer from 0 to 5; the sum of m&plus;n is greater than zero; a is 0 or 1; b is 0 or 1; g is 0 or 1; when b is 0, one of a and g must be 0; Z and Z′ are independently selected from O and S; X and X′. when present, are selected from O, S, and NR1, where R1 is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; T, when present, is selected from C&boxH;O, C&boxH;S, S&boxH;O, and SO2; when T is S&boxH;O or SO2, X and X′ may not be S; when either a, b or g is 1 for a radical R—(X)a—(T)b—(X′)g—, R for that radical is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; when a, b and g are all 0 for a radical and neither Z nor Z′ is S, R for that radical may be further selected from the group consisting of F, Cl, Br, I, CN, R2N→O, NO2; when Z or Z′ is S, R for that radical may be further selected from the group consisting of CN, R2N→O, NO2; when all a, b and g are 0, at least one R must be non-H; further provided that the total number of halogen atoms in the molecule excluding any present in G does not exceed two; G is H, a suitable charge balancing counterion (Mn&plus;)1/n, or a cleaveable group selected from the group consisting of Si((O)pR2)3, where p is independently 0 or 1; C(O)q((O)pR2)r, wherein p is independently 0 or 1 and when q is 1, r is 1, and when q is 0, r is 3; R2 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof; wherein the bacteria-reducing system reduces bacteria on a substrate where the active is incorporated or added via a solution or lotion, is provided. &lsqb;0028&rsqb; In still yet another aspect of the present invention, a method for bacteria-reducing a bacteria-containing substrate comprising contacting the substrate with a bacteria-reducing system according to the present invention, is provided. &lsqb;0029&rsqb; In even yet another aspect of the present invention, a bacteria-reduced substrate/article made by the method of present invention, is provided. &lsqb;0030&rsqb; In still yet another aspect of the present invention, a bacteria-reducing product comprising an antibacterial composition and/or bacteria-reducing system of the present invention, is provided. &lsqb;0031&rsqb; Accordingly, the present invention provides antibacterial compositions, bacteria-reducing systems, bacteria-reducing methods, bacteria-reducing products and bacteria-reduced substrates/articles made by the methods that employ an antibacterial agent, preferably a substituted salicylanilide. &lsqb;0032&rsqb; These and other objects, features and advantages will be clear from the following detailed description, examples and appended claims. &lsqb;0033&rsqb; All percentages, ratios and proportions herein are on a weight basis based on a neat product unless otherwise indicated. All documents cited herein are hereby incorporated by reference. DETAILED DESCRIPTION OF THE INVENTION &lsqb;0034&rsqb; Definitions &lsqb;0035&rsqb; “System”—“System” as used herein means a complex unity formed of many often, but not always, diverse parts (i.e.. materials, compositions, devices, appliances, procedures, methods, conditions, etc.) subject to a common plan or serving a common purpose. &lsqb;0036&rsqb; “Bacteria Reduced Substrate/Article”—“Bacteria Reduced Substrate/Article” as used herein means a substrate/article in which the bacteria present on and/or in the substrate/article have been reduced. &lsqb;0037&rsqb; “Substituted”—“Substituted” as used herein means that the organic composition or radical to which the term is applied is: &lsqb;0038&rsqb; (a) made unsaturated by the elimination of elements or radical; or &lsqb;0039&rsqb; (b) at least one hydrogen in the compound or radical is replaced with a moiety containing one or more (i) carbon, (ii) oxygen, (iii) sulfur, (iv) nitrogen or (v) halogen atoms; or &lsqb;0040&rsqb; (c) both (a) and (b). &lsqb;0041&rsqb; (i) Moieties which may replace hydrogen as described in (b) immediately above, which contain only carbon and hydrogen atoms are all hydrocarbon moieties including, but not limited to, alkyl, alkenyl, alkynyl, alkyldienyl, cycloalkyl, phenyl, alkyl phenyl, naphthyl, anthryl, phenanthryl, fluoryl, steroid groups, and combinations of these groups with each other and with polyvalent hydrocarbon groups such as alkylen, alkylidene and alkylidyne groups. Specific nonlimiting examples of such groups are: 4 &lsqb;0042&rsqb; (ii) Moieties containing oxygen atoms which may replace hydrogen as described in (b) immediately above include hydroxy, acyl or keto, ether, epoxy, carboxy, and ester containing groups. Specific nonlimiting examples of such oxygen containing groups are: &lsqb;0043&rsqb; —CH2OH, —CCH3CH3OH, —CH2COOH, —C(O)—(CH2)8CH3, —OCH2CH3, &boxH;O, —OH, —CH2—O—CH2CH3, —CH2—O—(CH2)2—OH, —CH2CH2COOH, -&phgr;OH, -&phgr;OCH2CH3, -&phgr;CH2OH, 5 &lsqb;0044&rsqb; (iii) Moieties containing sulfur atoms which may replace hydrogen as described in (b) immediately above include the sulfur-containing acids and acid ester groups, thioether groups, mercapto groups and thioketo groups. Specific nonlimiting examples of such sulfur containing groups are: &lsqb;0045&rsqb; —SCH2CH3, —CH2S(CH2)4CH3, —SO3CH2CH3, SO2CH2CH3, —CH2COSH, —SH, —CH2SCO, —CH2C(S)CH2CH3, —SO3H, —O(CH2)2C(S)CH3, &boxH;S, and 6 &lsqb;0046&rsqb; (iv) Moieties containing nitrogen atoms which may replace hydrogen as described in (b) immediately above include amino groups, the nitro group, azo groups, ammonium groups, amide groups, azido groups, isocyanate groups, cyano groups and nitrile groups. Specific nonlimiting examples of such nitrogen containing groups are: &lsqb;0047&rsqb; —NHCH3, —NH2, —NH3&plus;, —CH2CONH2, —CH2CON3, —CH2CH2CH&boxH;NOH, —CN, —CH(CH3)CH2NCO, —CH2NCO, —N&phgr;, -&phgr;N&boxH;N&phgr;OH, and ≡N. &lsqb;0048&rsqb; (v) Moieties containing halogen atoms which may replace hydrogen as described in (b) immediately above include chloro, bromo, fluoro, iodo groups and any of the moieties previously described where a hydrogen or a pendant alkyl group is substituted by a halo group to form a stable substituted moiety. Specific nonlimiting examples of such halogen containing groups are: &lsqb;0049&rsqb; —(CH2)3COCl, -&phgr;F5, -&phgr;Cl, —CF3, and —CH2&phgr;Br. &lsqb;0050&rsqb; It is understood that any of the above moieties (i) through (v) can be substituted into each other in either a monovalent substitution or by loss of hydrogen in a polyvalent substitution to form another monovalent moiety which can replace hydrogen in the organic compound or radical. &lsqb;0051&rsqb; “&phgr;”—“&phgr;” as used herein represents a phenyl ring. &lsqb;0052&rsqb; Antibacterial Agent &lsqb;0053&rsqb; The antibacterial agent useful in the present invention preferably comprises a substituted phenol compound of formula II: 7 &lsqb;0054&rsqb; wherein m is an integer from 0 to 4; a is 0 or 1; b is 0 or 1; g is 0 or 1; when b is 0, one of a and g must be 0; Z is selected from O and S; X and X′, when present, are selected from O, S, and NR1; when either a, b or g is 1 for a radical R—(X)a—(T)b—(X′)g—, R for that radical is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; when a, b and g are all 0 for a radical, R for that radical may be further selected from the group consisting of F, Cl, Br, I, CN, R2N→O, NO2; T, when present, is selected from C&boxH;O, C&boxH;S, S&boxH;O, and SO2; when T is S&boxH;O or SO2, X and X′ may not be S; Y is a radical comprising at least 1 but no more than 20 carbon atoms and containing a substituent —X″—H, where X″ is selected from O, S, and N—(T′)b′—(X′″)a′— R2, where a′ is 0 or 1, b′ is 0 or 1, and X′″, when present, is selected from O, S, and NR2; R2 is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; T′, when present, is selected from C&boxH;O, C&boxH;S, and SO2; when T′ is SO2, X′″ may not be S; G is H, a suitable charge balancing counterion (Mn&plus;)1/n, or a cleaveable group selected from the group consisting of Si((O)pR3)3, where p is independently 0 or 1; C(O)q((O)pR3)r, wherein p is independently 0 or 1 and when q is 1, r is 1, and when q is 0, r is 3; R3 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof; the parameter dZ-H, the center to center distance from the phenolic oxygen atom or the thiophenolic sulfur atom to the H atom of —X″—H, must satisfy the following criterion in at least one rotational conformation of the compound II: 1.0 &angst;&lE;dZ-H&lE;4.0 &angst;; &lsqb;0055&rsqb; wherein when G is H or replaced by H, the pKa of the substituted phenol or thiophenol, or resulting substituted phenol or thiophenol is from about 5 to about 11. &lsqb;0056&rsqb; More preferably, the antibacterial agent comprises the substituted phenol compound of formula II wherein G is C(O)q((O)pR1)r, wherein p is independently 0 or 1 and when q is 1, r is 1, and when q is 0, r is 3; R1 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof. &lsqb;0057&rsqb; Even more preferably, the antibacterial agent comprises a salicylanilide compound, preferably a substituted salicylanilide compound having the formula I: 8 &lsqb;0058&rsqb; wherein m is an integer from 0 to 4; n is an integer from 0 to 5; the sum of m&plus;n is greater than zero; a is 0 or 1; b is 0 or 1; g is 0 or 1; when b is 0, one of a and g must be 0; Z and Z′ are independently selected from O and S; X and X′, when present, are selected from O, S, and NR1, where R1 is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; T, when present, is selected from C&boxH;O, C&boxH;S, S&boxH;O, and SO2; when T is S&boxH;O or SO2, X and X′ may not be S; when either a, b or g is 1 for a radical R—(X)a—(T)b—(X′)g—, R for that radical is independently selected from the group consisting of H, C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl; when a, b and g are all 0 for a radical and neither Z nor Z′ is S, R for that radical may be further selected from the group consisting of F, Cl, Br, I, CN, R2N→O, NO2; when Z or Z′ is S, R for that radical may be further selected from the group consisting of CN, R2N→O, NO2; when all a, b and g are 0, at least one R must be non-H; further provided that the total number of halogen atoms in the molecule excluding any present in G does not exceed two; G is H, a suitable charge balancing counterion (Mn&plus;)1/n, or a cleaveable group selected from the group consisting of Si((O)pR2)3, where p is independently 0 or 1; C(O)q((O)pR2)r, wherein p is independently 0 or 1 and when q is 1, r is 1, and when q is 0, r is 3; R2 is independently selected from the group consisting of C1-C16 linear or branched, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, alkaryl, aralkyl, and aryl, and mixtures thereof. &lsqb;0059&rsqb; Specific nonlimiting examples of substitutions that can be made on the salicylanilide rings include the following: 9 &lsqb;0060&rsqb; In a more preferred embodiment of the present invention, the antibacterial agent comprises a salicylanilide compound having the formula I wherein m is an integer from 0 to 2; n is an integer from 0 to 2; g is 0; Z and Z′ are 0; and T, when present, is selected from C&boxH;O and SO2. &lsqb;0061&rsqb; In preferred embodiments of the present invention, the antibacterial agents are selected from monosubstituted salicylanilides, including but not limited to, 5-chlorosalicylanilide, 4-chlorosalicylanilide, 5-iodosalicyanilide, 4-iodosalicylanilide, 5-fluorosalicylanilide, 4-fluorosalicylanilide, 5-cyanosalicylanilide, 4-cyanosalicylanilide, 5-acetylsalicylanilide, and 4-acetylsalicylanilide. The salts of the aforementioned compounds are also a preferred species. &lsqb;0062&rsqb; In more preferred embodiments of the present invention, the antibacterial agents are selected from monohalogenated salicylanilide compounds, preferably 4-halosalicylanilide and 5-halosalicylanilide, more preferably 4-chlorosalicylanilide and 5-chlorosalicylanilide, most preferably 5-chlorosalicylanilide. &lsqb;0063&rsqb; In highly preferred embodiments of the present invention, the antibacterial agents are selected from monohalogenated salicylanilide compounds, preferably 4-halosalicylanilide and 5-halosalicylanilide, more preferably 4-chlorosalicylanilide and 5-chlorosalicylanilide, most preferably 5-chlorosalicylanilide. &lsqb;0064&rsqb; Bacteria-Reducing System &lsqb;0065&rsqb; The antibacterial agent of the present invention is useful in reducing bacteria on a substrate/article, when the antibacterial agent is incorporated into a bacteria-reducing system. &lsqb;0066&rsqb; Preferably, such a bacteria-reducing system further comprises a surfactant and/or a solvent and/or a perfume and/or an enzyme. &lsqb;0067&rsqb; In a preferred embodiment of the present invention, a bacteria-reducing system comprising: &lsqb;0068&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0069&rsqb; b) at least 1% by weight of the composition of a surfactant; &lsqb;0070&rsqb; wherein the weight ratio of the surfactant to the antibacterial agent is greater than or equal to 1.0, is provided. &lsqb;0071&rsqb; Optionally, but preferably, this bacteria-reducing system further comprises a perfume having a C log P greater than or equal to 2.0. &lsqb;0072&rsqb; In another preferred embodiment of the present invention, a bacteria-reducing system comprising: &lsqb;0073&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0074&rsqb; b) from about 0.5% to about 90% by weight of the composition of a solvent whose Hildebrand solubility parameter &dgr;S (cal/cm3)1/2 meets the following criterion: 5<&dgr;S<20; &lsqb;0075&rsqb; wherein a 10 wt % aqueous solution of the composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the antibacterial agent where —Z—G is —Z—H, is provided. &lsqb;0076&rsqb; Optionally, but preferably, this bacteria-reducing system further comprises a perfume having a C log P greater than or equal to 2.0. &lsqb;0077&rsqb; In yet another preferred embodiment of the present invention, a bacteria-reducing system comprising: &lsqb;0078&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0079&rsqb; b) from about 0.001%, preferably from about 0.01%, more preferably from about 0.1%, most preferably from about 0.5% to about 30%, preferably to about 20%, more preferably to about 10%, most preferably to about 5% by weight of the composition of a perfume wherein the perfume has a C log P greater than or equal to 1.0, preferably 1.5 more preferably 2.0, is provided. &lsqb;0080&rsqb; In still yet another embodiment of the present invention, a bacteria-reducing system comprising: &lsqb;0081&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; &lsqb;0082&rsqb; b) at least 1% by weight of the composition of a surfactant; &lsqb;0083&rsqb; wherein the weight ratio of the surfactant to the antibacterial agent is greater than or equal to 1.0; and &lsqb;0084&rsqb; c) from about 0.5% to about 90% by weight of the composition of a solvent whose Hildebrand solubility parameter &dgr;S (cal/cm3)1/2 meets the following criterion: 5<&dgr;S<20; &lsqb;0085&rsqb; wherein a 10wt % aqueous solution of the composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the antibacterial agent where -Z-G is -Z-H, is provided. &lsqb;0086&rsqb; The substrate may be a hard or soft substrate. Hard substrates are selected from the group consisting of: utensils, dishes, countertops, cookware, pots, pans, skillets, baby bottles, baby nipples, glassware, dentures, kitchen cutting boards made of wood or any other suitable material, and mixtures thereof. Soft substrates are selected from the group consisting of: textiles, fabrics, garments, sponges, wash cloths, brushes, gloves, scouring pads, reusable wipes, animal and human skin (i.e., personal cleansing applications) and mixtures thereof. In addition to these substrates, the substrates may include food articles, such as fruits, meats and liquids, such as water. &lsqb;0087&rsqb; The bacteria on and/or in the substrate is preferably selected from the group consisting of: Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus capitis, Klebsiella pneumoniae, Proteus mirabilis, Serratia marcescens, Staphylococcus epidermis, Salmonella typhimurium, Shigella dysenteriae, Streptococcus faecalis, Streptococcus pyogenes, Cornybacterium xerosis, Micrococcus varians, Micrococcus luteus, Peptostreptococcus anaerobius, Propionibacterium acnes, Propionibacterium avidum, Propionibacterium granulosum, Escherichia coli, Salmonella choleraesius, Listeria monocytogenes, Enterococcus hirae and mixtures thereof more preferably. Escherichia coli, Salmonella choleraesius, Listeria monocytogenes and mixtures thereof, and most preferably Escherichia coli, Salmonella choleraesius and mixtures thereof. &lsqb;0088&rsqb; Antibacterial Composition &lsqb;0089&rsqb; The antibacterial agent of the present invention is preferably incorporated with one or more additional adjunct ingredients into one or more antibacterial compositions. Preferably, the antibacterial compositions of the present invention are free of aminopolyureylene resin because unlike prior art antibacterial compositions the antibacterial agents and systems and compositions of the present invention exhibit relatively dilute efficacy and do not require a resin to attach the antibacterial agents to a substrate to be efficacious. &lsqb;0090&rsqb; These one or more additional adjunct ingredients are determined according to the type of composition that the antibacterial agent is to be incorporated into and/or the type of use of the antibacterial composition. &lsqb;0091&rsqb; The antibacterial agent can be incorporated into a range of different compositions and/or products including, but not limited to, liquid dishwashing detergent compositions, heavy duty detergent compositions, automatic dishwashing compositions, hard surface cleaning compositions, home care compositions, fabric care compositions and dryer-added compositions. These compositions and/or products may be in any form known to those skilled in the art. For example, the compositions and/or products may be in liquid, granular, powder, tablet, paste, foam and bars. These compositions and/or products may be neat or releasably absorbed or adsorbed on to a substrate, such as a woven or non-woven filament substrate. &lsqb;0092&rsqb; For example, an antibacterial composition in accordance with the present invention preferably comprises an antibacterial agent of the present invention with a surfactant, preferably at least 1% by weight of the composition of a surfactant, and/or a solvent, preferably from about 0.5% to 90% by weight of the composition of a solvent whose Hildebrand solubility parameter &dgr;S (cal/cm3)1/2 meets the following criterion: 5<&dgr;S<20, and wherein a 10wt % aqueous solution of the composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the antibacterial agent where —Z—G is —Z—H, and/or a perfume, preferably a perfume wherein the perfume has a C log P greater than or equal to 2.0, and/or an enzyme. Optionally, but preferably, the composition comprises one or more additional detergent adjunct ingredients selected from the group consisting of: bleaching systems, brighteners, builders, chelants, soil release polymers, dye transfer inhibiting agents. &lsqb;0093&rsqb; In a preferred embodiment of the present invention, an antibacterial composition comprising: &lsqb;0094&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0095&rsqb; b) at least 1% by weight of the composition of a surfactant; &lsqb;0096&rsqb; wherein the weight ratio of the surfactant to the antibacterial agent is greater than or equal to 1.0, is provided. &lsqb;0097&rsqb; Optionally, but preferably, this antibacterial composition further comprises a perfume oil, preferably a hydrophobic perfume oil. &lsqb;0098&rsqb; In another preferred embodiment of the present invention, an antibacterial composition comprising: &lsqb;0099&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0100&rsqb; b) from about 0.5% to about 90% by weight of the composition of a solvent whose Hildebrand solubility parameter &dgr;S (cal/cm3)1/2 meets the following criterion: 5<&dgr;S<20; &lsqb;0101&rsqb; wherein a 10 wt % aqueous solution of the composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the antibacterial agent where —Z—G is —Z—H, is provided &lsqb;0102&rsqb; Optionally, but preferably, this antibacterial composition further comprises a perfume oil, preferably a hydrophobic perfume oil. &lsqb;0103&rsqb; In yet another preferred embodiment of the present invention, an antibacterial composition comprising: &lsqb;0104&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; and &lsqb;0105&rsqb; b) from about 0.001%, preferably from about 0.01%, more preferably from about 0.1%, most preferably from about 0.5% to about 30%, preferably to about 20%, more preferably to about 10%, most preferably to about 5% by weight of the composition of a perfume wherein the perfume has a C log P greater than or equal to 1.0, preferably 1.5 more preferably 2.0, is provided. &lsqb;0106&rsqb; In still yet another embodiment of the present invention, an antibacterial composition comprising: &lsqb;0107&rsqb; a) an effective amount, preferably from about 0.001%, more preferably from about 0.01%, even more preferably from about 0.05% to about 15%, more preferably to about 10%, even more preferably to about 5%, most preferably to about 2.5% by weight of the system of an antibacterial agent of the present invention; &lsqb;0108&rsqb; b) at least 1% by weight of the composition of a surfactant; &lsqb;0109&rsqb; wherein the weight ratio of the surfactant to the antibacterial agent is greater than or equal to 1.0; and &lsqb;0110&rsqb; c) from about 0.5% to about 90% by weight of the composition of a solvent whose Hildebrand solubility parameter &dgr;S (cal/cm3)1/2 meets the following criterion: 5<&dgr;S<20; &lsqb;0111&rsqb; wherein a 10 wt % aqueous solution of the composition has a pH&gE;(pKa−1) where pKa is the calculated pKa of the antibacterial agent where —Z—G is —Z—H, is provided. &lsqb;0112&rsqb; Dilute Efficacy Test Protocol &lsqb;0113&rsqb; The antibacterial compositions and/or antibacterial products and/or bacteria-reducing systems, preferably antibacterial compositions of the present invention exhibit relatively dilute efficacy in reducing bacteria from substrates/articles as measured by this Dilute Efficacy Test. &lsqb;0114&rsqb; To determine whether an antibacterial composition and/or antibacterial product and/or bacteria-reducing system comprising an antibacterial agent of the present invention satisfies this Dilute Efficacy Test, a Dilute Efficacy Test Protocol has been established. This Dilute Efficacy Test Protocol is a modification of AOAC Official Method 960.09. &lsqb;0115&rsqb; Step 1: Dilute a 0.25% by weight antibacterial agent containing composition or product or system with hard water (14 grains per gallon) to a 1:3 dilution in the presence of 5% soil (horse serum commercially available from Sigma). &lsqb;0116&rsqb; Step 2: Contact at 25° C. for 30 minutes the dilute solution from Step I with 106 cfu/ml of a one of the three gram negative bacteria: Salmonella choleraesuis ATCC&num; 10708, Klebsiella pneumoniae ATCC&num; 4352 and Escherichia coli ATCC&num; 11229, the nutrient medium that the bacteria are grown in is Nutrient agar or Trypticase soy broth, and the incubation conditions for the bacteria are 37° C. for 24 hours. &lsqb;0117&rsqb; Step 3: Neutralize the antibacterial agent by adding a 1:10 dilution of neutralizer broth (1×concentration of DIE Neutralizing Broth commercially available from Difco Laboratories, 9.5% Tween 80 and 2.5% sodium thiosulfate) to the solution of Step 2. &lsqb;0118&rsqb; Step 4: Determine the log reduction by the plate count method or using a bactometer to determine the log remaining bacteria. &lsqb;0119&rsqb; Step 5: If the log reduction for Salmonella choleraesuis ATCC&num; 10708 or Klebsiella pneumoniae ATCC&num; 4352 or Escherichia coli ATCC&num; 11229 is 2 or greater, preferably 3 or greater, more preferably 4 or greater, most preferably 5 or greater, the antibacterial agent containing composition, product or system exhibits Dilute Efficacy within the scope of the present invention. &lsqb;0120&rsqb; Adjunct Ingredients &lsqb;0121&rsqb; In addition to the antibacterial agent, one or more adjunct ingredients as described below may optionally, but preferably, be included in the compositions, products and/or systems comprising the antibacterial agent. &lsqb;0122&rsqb; Examples of suitable adjunct ingredients include, but are not limited to, builders, bleaches, bleach activators, bleach catalysts, enzyme stabilizing systems, chelants, optical brighteners, soil release polymers, dye transfer agents, dispersants, suds suppressors, dyes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, hydrolyzable surfactants, perservatives, anti-oxidants, anti-shrinkage agents, anti-wrinkle agents, germicides, fungicides, color speckles, silvercare, anti-tarnish and/or anti-corrosion agents, alkalinity sources, solubilizing agents, carriers, processing aids, pigments and pH control agents as described in U.S. Pat. Nos. 5,705,464, 5,710,115, 5,698,504, 5,695,679, 5,686,014 and 5,646,101. Specific cleaning adjunct materials are exemplified in detail hereinafter. &lsqb;0123&rsqb; Preferred Adjunct Ingredients &lsqb;0124&rsqb; Surfactants—A wide range of surfactants can be used in the compositions of the present invention. &lsqb;0125&rsqb; Surfactants included in the fully-formulated compositions afforded by the present invention comprise at least 0.01%, preferably at least about 0.1%, more preferably at least about 0.5%, even more preferably at least about 1%, most preferably at least about 3% to about 80%, more preferably to about 60%, most preferably to about 50% by weight of composition depending upon the particular surfactants used and the desired effects to be achieved. &lsqb;0126&rsqb; The surfactant can be nonionic, anionic, amphoteric, amphophilic, zwitterionic, cationic, semi-polar nonionic, and mixtures thereof, nonlimiting examples of which are disclosed in U.S. Pat. Nos. 5,707,950 and 5,576,282. A typical listing of anionic, nonionic, amphoteric and zwitterionic classes, and species of these surfactants, is given in U.S. Pat. No. 3,664,961 issued to Norris on May 23, 1972. Preferred compositions comprise nonionic surfactants and/or mixtures of nonionic surfactants with other surfactants, especially anionic surfactants. &lsqb;0127&rsqb; i. Nonionic Surfactant &lsqb;0128&rsqb; Suitable nonionic surfactants are generally disclosed in U.S. Pat. No. 3,929,678, Laughlin et al., issued Dec. 30, 1975, and U.S. Pat. No. 4,285,841, Barrat et al, issued Aug. 25, 1981. Exemplary, non-limiting classes of useful nonionic surfactants include: C8-C18 alkyl ethoxylates (“AE”), with EO about 1-22, including the so-called narrow peaked alkyl ethoxylates and C6-C12 alkyl phenol alkoxylates (especially ethoxylates and mixed ethoxy/propoxy), alkyl dialkyl amine oxide, alkanoyl glucose amide, and mixtures thereof. &lsqb;0129&rsqb; If nonionic surfactants are used, the compositions of the present invention will preferably contain from about 1% to about 80%, more preferably from about 1% to about 60%, most preferably from about 1% to about 50% by weight of nonionic surfactant. &lsqb;0130&rsqb; Preferred nonionic surfactants include, but are not limited to, the ethoxylated alcohols and ethoxylated alkyl phenols of the formula R(OC2H4)nOH, wherein R is selected from the group consisting of aliphatic hydrocarbon radicals containing from about 8 to about 15 carbon atoms and alkyl phenyl radicals in which the alkyl groups contain from about 8 to about 12 carbon atoms, and the average value of n is from about 5 to about 15. These surfactants are more fully described in U.S. Pat. No. 4,284,532. Leikhim et al, issued Aug. 18, 1981. Particularly preferred are ethoxylated alcohols having an average of from about 9 to abut 15 carbon atoms in the alcohol and an average degree of ethoxylation of from about 5 to about 15 moles of ethylene oxide per mole of alcohol. &lsqb;0131&rsqb; Other nonionic surfactants for use herein include: &lsqb;0132&rsqb; The polyethylene, polypropylene, and polybutylene oxide condensates of alkyl phenols. Commercially available nonionic surfactants of this type include Igepal® CO-630, marketed by the GAF Corporation; and Triton® X45, X-114, X-100, and X-102, all marketed by the Rohm & Haas Company. These compounds are commonly referred to as alkyl phenol alkoxylates, (e.g., alkyl phenol ethoxylates). &lsqb;0133&rsqb; The condensation products of aliphatic alcohols with from about 1 to about 25 moles of ethylene oxide. Examples of commercially available nonionic surfactants of this type include Tergitol® 15-S-9 (the condensation product of C11-C15 linear secondary alcohol with 9 moles ethylene oxide), Tergitol® 24-L-6 NMW (the condensation product of C12-C14 primary alcohol with 6 moles ethylene oxide with a narrow molecular weight distribution), both marketed by Union Carbide Corporation; Neodol® 45-9 (the condensation product of C14-C15 linear alcohol with 9 moles of ethylene oxide), Neodol® 23-9 (the condensation product of C12-C13 linear alcohol with 9 moles of ethylene oxide); Neodol® 23-6.5 (the condensation product of C12-C13 linear alcohol with 6.5 moles of ethylene oxide), Neodol® 45-7 (the condensation product of C14-C15 linear alcohol with 7 moles of ethylene oxide), Neodol® 45-4 (the condensation product of C14-C15 linear alcohol with 4 moles of ethylene oxide), marketed by Shell Chemical Company, and Kyro® EOB (the condensation product of C13-C15 alcohol with 9 moles ethylene oxide), marketed by The Procter & Gamble Company. Other commercially available nonionic surfactants include Dobanol 91-8® marketed by Shell Chemical Co. and Genapol UD-080® marketed by Hoechst. This category of nonionic surfactant is referred to generally as “alkyl ethoxylates.” &lsqb;0134&rsqb; The condensation products of ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol. Examples of compounds of this type include certain of the commercially-available Pluronic® surfactants, marketed by BASF. &lsqb;0135&rsqb; The condensation products of ethylene oxide with the product resulting from the reaction of propylene oxide and ethylenediamine. Examples of this type of nonionic surfactant include certain of the commercially available Tetronic® compounds, marketed by BASF. &lsqb;0136&rsqb; Semi-polar nonionic surfactants, especially water-soluble amine oxides. Preferably, these amine oxide surfactants include C10-C18 alkyl dimethyl amine oxides and C8-C12 alkoxy ethyl dihydroxy ethyl amine oxides. &lsqb;0137&rsqb; Alkylpolysaccharides disclosed in U.S. Pat. No. 4,565,647, Llenado, issued Jan. 21, 1986, having a hydrophobic group containing from about 6 to about 30 carbon atoms, and alkylpolyglycosides disclosed in EP-B 070 077 EP-B-075 996 and EP-B 094 118. &lsqb;0138&rsqb; Fatty acid amide surfactants having the formula: 10 &lsqb;0139&rsqb; wherein R6 is an alkyl group containing from about 7 to about 21 (preferably from about 9 to about 17) carbon atoms and each R7 is selected from the group consisting of hydrogen, C1-C4 alkyl, C1-C4 hydroxyalkyl, and —(C2H4O)xH where x varies from about 1 to about 3. Preferred amides are C8-C20 ammonia amides, monoethanolamides, dietha-nolamides, and isopropanolamides. &lsqb;0140&rsqb; These and other nonionic surfactants are well known in the art, being described in more detail in Kirk Othmer's Encyclopedia of Chemical Technology, 3rd Ed., Vol. 22, pp. 360-379, “Surfactants and Detersive Systems”, incorporated by reference herein. &lsqb;0141&rsqb; ii. Anionic Surfactant &lsqb;0142&rsqb; Generally speaking, anionic surfactants useful herein are disclosed in U.S. Pat. No. 4,285,841, Barrat et al. issued Aug. 25, 1981, and in U.S. Pat. No. 3,919,678, Laughlin et al, issued Dec. 30, 1975, both incorporated herein by reference. &lsqb;0143&rsqb; Anionic surfactants include, but are not limited to, linear alkylbenzene sulfonate, alpha olefin sulfonate, paraffin sulfonates, alkyl ester sulfonates, alkyl sulfates, alkyl alkoxy sulfate, alkyl sulfonates, alkyl alkoxy carboxylate, alkyl alkoxylated sulfates, sarcosinates, taurinates, and mixtures thereof. More preferably, the anionic surfactants include, but are not limited to, C1l-C18 alkyl benzene sulfonates (LAS) and primary, branched-chain and random C10-C20 alkyl sulfates (AS), the C10-C18 secondary (2.3) alkyl sulfates of the formula CH3(CH2)x(CHOSO3−M&plus;) CH3 and CH3 (CH2)y(CHOSO3−M&plus;) CH2CH3 where x and (y&plus;1) are integers of at least about 7, preferably at least about 9, and M is a water-solubilizing cation, especially sodium, unsaturated sulfates such as oleyl sulfate, the C10-C18 alkyl alkoxy sulfates (“AExS”; especially EO 1-7 ethoxy sulfates, such as 1.8 and 1.1), C10-C18 alkyl alkoxy carboxylates (especially the EO 1-11 ethoxycarboxylates), the C10-C18 sulfated glycerol ethers, the C10-C18 sulfated alkyl polyglycosides, and C12-C18 alpha-sulfonated fatty acid esters. &lsqb;0144&rsqb; Useful anionic surfactants include the water-soluble salts, particularly the alkali metal, ammonium and alkylolammonium (e.g., monoethanolammonium or triethanolammonium) salts, of organic sulfuric reaction products having in their molecular structure an alkyl group containing from about 10 to about 20 carbon atoms and a sulfonic acid or sulfuric acid ester group. (Included in the term “alkyl” is the alkyl portion of aryl groups.) Examples of this group of synthetic surfactants are the alkyl sulfates, especially those obtained by sulfating the higher alcohols (C8-C18 carbon atoms) such as those produced by reducing the glycerides of tallow or coconut oil. Especially valuable are linear straight chain alkylbenzene sulfonates in which the average number of carbon atoms in the alkyl group is from about 11 to 13, abbreviated as C11-C13LAS. &lsqb;0145&rsqb; Further examples are described in “Surface Active Agents and Detergents” (Vol. I and II by Schwartz, Perry and Berch) and in U.S. Pat. No. 3,929,678, issued Dec. 30, 1975 to Laughlin, et al. at Column 23, line 58 through Column 29, line 23 (herein incorporated by reference). &lsqb;0146&rsqb; Highly preferred anionic surfactants include alkyl alkoxylated sulfate surfactants hereof are water soluble salts or acids of the formula RO(A)mSO3M wherein R is an unsubstituted C10-C24 alkyl or hydroxyalkyl group having a C10-C24 alkyl component, preferably a C12-C20 alkyl or hydroxyalkyl, more preferably C12-C18 alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about 0.5 and about 3, and M is H or a cation which can be, for example, a metal cation (e.g., sodium, potassium, lithium, calcium, magnesium. etc.), ammonium or substituted-ammonium cation. Alkyl ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein. Specific examples of substituted ammonium cations include methyl-, dimethyl, trimethyl-ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and those derived from alkylamines such as ethylamine, diethylamine, triethylamine, mixtures thereof, and the like. Exemplary surfactants are C12-C18 alkyl polyethoxylate (1.0) sulfate (C12-C18E(1.0)M), C12-C18 alkyl polyethoxylate (2.25) sulfate (C12-C18E(2.25)M), C12-C18 alkyl polyethoxylate (3.0) sulfate (C12-C18E(3.0)M), and C12-C18 alkyl polyethoxylate (4.0) sulfate (C12-C18E(4.0)M), wherein M is conveniently selected from sodium and potassium. &lsqb;0147&rsqb; When included therein, the compositions of the present invention typically comprise from about 0.5%, preferably from about 3%, more preferably from about 5%, most preferably from about 10% to about 90%, preferably to about 50%, more preferably to about 20%, most preferably to about 10% by weight of such anionic surfactants. &lsqb;0148&rsqb; iii. Cosurfactants &lsqb;0149&rsqb; The compositions of the present invention may further comprise, especially when anionic surfactants are present, a cosurfactant selected from the group of primary or tertiary amines. Suitable primary amines for use herein include amines according to the formula: R1NH2 &lsqb;0150&rsqb; wherein R1 is a C6-C12, preferably C6-C10 alkyl chain, or R4X(CH2)n, wherein X is —O—, —C(O)NH— or —NH—, R4 is a C6-C12 alkyl chain n is between 1 to 5, preferably 3. R1 alkyl chains may be straight or branched and may be interrupted with up to 12, preferably less than 5 ethylene oxide moieties; or 11 &lsqb;0151&rsqb; wherein R1 is a C6-C12 alkyl group; n is from about 1 to 5, preferably 2 to about 4, more preferably 3. X is a bridging group which is selected from —NH—, —C(O)NH—, —C(O)O—, or —O— or X can be absent; and R3 and R4 are individually selected from H, C1-C4 alkyl, or (CH2—CH2—O(R5)) wherein R5 is H or methyl; &lsqb;0152&rsqb; Preferred amines according to the formula herein above are n-alkyl amines. Suitable amines for use herein may be selected from 1-hexylamine, 1-octylamine, 1-decylamine and laurylamine. Other preferred primary amines include C8-C10 oxypropylamine, octyloxypropylamine, 2-ethylhexyl-oxypropylamine, lauryl amido propylamine and amido propylamine. The most preferred amines for use in the compositions herein are 1-hexylamine, 1-octylamine, 1-decylamine, 1-dodecylamine. Especially desirable are n-dodecyldimethylamine and bishydroxyethylcoconutalkylamine and oleylamine 7 times ethoxylated, lauryl amido propylamine and cocoamido propylamine. &lsqb;0153&rsqb; Preferred amines include the following: R1—(CH2)2—NH2 (1) R1—O—(CH2)3—NH2 (2) R1—C(O)—NH—(CH2)3—N(CH3)2 (3) 12 &lsqb;0154&rsqb; wherein R1 is a C6-C12 alkyl group and R5 is H or CH3. &lsqb;0155&rsqb; In a highly preferred embodiment, the amine is described by the formula: R1—C(O)—NH—(CH2)3—N(CH3)2 &lsqb;0156&rsqb; wherein R1 is C8-C12 alkyl. &lsqb;0157&rsqb; Particularly preferred amines include those selected from the group consisting of octyl amine, hexyl amine, decyl amine, dodecyl amine, C8-C12 bis(hydroxyethyl)amine, C8-C12 bis(hydroxyisopropyl)amine, and C8-C12 amido-propyl dimethyl amine, and mixtures. &lsqb;0158&rsqb; If utilized the detersive amines comprise from about 0.1% to about 10%, preferably from about 0.5% to about 5%, by weight of the composition. &lsqb;0159&rsqb; iv. Quaternary Ammonium Surfactants &lsqb;0160&rsqb; Suitable quaternary ammonium surfactants include, but are not limited to, quaternary ammonium surfactants having the formula: 13 &lsqb;0161&rsqb; wherein R1 and R2 are individually selected from the group consisting of C1-C4 alkyl, C1-C4 hydroxy alkyl, benzyl, and —(C2H4O)xH where x has a value from about 2 to about 5; X is an anion; and (1) R3 and R4 are each a C6-C14 alkyl or (2) R3 is a C6-C18 alkyl, and R4 is selected from the group consisting of C1-C10 alkyl, C1-C10 hydroxy alkyl, benzyl, and —(C2H4O)xH where x has a value from 2 to 5. &lsqb;0162&rsqb; Preferred quaternary ammonium surfactants are the chloride, bromide, and methylsulfate salts. Examples of preferred mono-long chain alkyl quaternary ammonium surfactants are those wherein R1, R2, and R4 are each methyl and R3 is a C8-C16 alkyl; or wherein R3 is C8-18 alkyl and R1, R2, and R4 are selected from methyl and hydroxy-alkyl moieties. Lauryl trimethyl ammonium chloride, myristyl trimethyl ammonium chloride, palmityl trimethyl ammonium chloride, coconut trimethylammonium chloride, coconut trimethylammonium methylsulfate, coconut dimethyl-monohydroxyethyl-ammonium chloride, coconut dimethyl-monohydroxyethylammonium methylsulfate, steryl dimethyl-monohydroxy-ethylammonium chloride, steryl dimethylmonohydroxy-ethylammonium methylsulfate, di- C12-C14 alkyl dimethyl ammonium chloride, and mixtures thereof are particularly preferred. ADOGEN 412™, a lauryl trimethyl ammonium chloride commercially available from Witco, is also preferred. Even more highly preferred are the lauryl trimethyl ammonium chloride and myristyl trimethyl ammonium chloride. &lsqb;0163&rsqb; Alkoxylated quaternary ammonium (AQA) surfactants useful in the present invention are of the general formula: 14 &lsqb;0164&rsqb; wherein R1 is an alkyl or alkenyl moiety containing from about 8 to about 18 carbon atoms, preferably 10 to about 16 carbon atoms, most preferably from about 10 to about 14 carbon atoms; R2 and R3′ are each independently alkyl groups containing from one to about three carbon atoms, preferably methyl; R3 and R4 can vary independently and are selected from hydrogen (preferred), methyl and ethyl, X− is an anion such as chloride, bromide, methylsulfate, sulfate, or the like, to provide electrical neutrality; A is selected from C1-C4 alkoxy, especially ethoxy (i.e., —CH2CH2O—), propoxy, butoxy and mixtures thereof; and for formula I, p is from 2 to about 30, preferably 2 to about 15, most preferably 2 to about 8; and for formula II, p is from 1 to about 30, preferably 1 to about 4 and q is from 1 to about 30, preferably 1 to about 4, and most preferably both p and q are 1. &lsqb;0165&rsqb; Other quaternary surfactants include the ammonium surfactants such as alkyldimethylammonium halogenides, and those surfactants having the formula: &lsqb;R2(OR3)y&rsqb;&lsqb;R4(OR3)y&rsqb;2R5N&plus;X− &lsqb;0166&rsqb; wherein R2 is an alkyl or alkyl benzyl group having from about 8 to about 18 carbon atoms in the alkyl chain, each R3 is selected from the group consisting of —CH2CH2—, —CH2CH(CH3)—, —CH2CH(CH2OH)—, —CH2CH2CH2—, and mixtures thereof; each R4 is selected from the group consisting of C1-C4 alkyl, C1-C4 hydroxyalkyl, benzyl, ring structures formed by joining the two R4 groups, —CH2CHOHCHOHCOR6CHOH—CH2OH wherein R6 is any hexose or hexose polymer having a molecular weight less than about 1000, and hydrogen when y is not O; R5 is the same as R4 or is an alkyl chain wherein the total number of carbon atoms of R2 plus R5 is not more than about 18; each y is from 0 to about 10 and the sum of the y values is from 0 to about 15: and X is any compatible anion. &lsqb;0167&rsqb; v. Fatty Acid &lsqb;0168&rsqb; Suitable fatty acids that can be incorporated into the compositions of the present invention in addition to surfactants, include, but are not limited to, saturated and/or
{'app_number': '09784500', 'application_number': None, 'doc_number': '20020068014', 'publication_number': None, 'source_file': './application/2002/pa020606.xml', 'source_data': 'USPTO-Application'}